Joelle Goulding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joelle Goulding has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Stephen J. Hill
Cell Signalling and Pharmacology Research Group, Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, UK
9 shared publications Stephen J. Briddon
Centre of Membrane Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, The Midlands, Nottingham NG7 2UH, U.K.
6 shared publications- Barrie Kellam
Centre of Membrane Proteins and Receptors (COMPARE) University of Birmingham and University of Nottingham Midlands UK
5 shared publications - Laura E. Kilpatrick
University of Nottingham
4 shared publications Nicholas D. Kindon
School of Pharmacy, Division of Bimolecular Science and Medicinal Chemistry, Biodiscovery Institute
4 shared publications- Stephen J. Briddon
Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom
4 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Elsevier in SSRN Electronic Journal
The Tspan15/ADAM10 molecular scissor promotes cell invasion through an N-cadherin/FGFR signaling axis
The ’molecular scissor’ ADAM10 is a critical regulator of cell surface signal transduction, but its therapeutic potential is constrained by the anticipated side effects of global inhibition. ADAM10 activity is governed by six regulatory tetraspanins, the TspanC8s, which dictate its substrate specificity. Among these, Tspan15 is upregulated in aggressive cancers and promotes cell invasion and cancer growth in vivo, however definitive genetic evidence for its ADAM10-dependence and its precise signaling mechanism are lacking. Utilizing HEK-293T cells to isolate the Tspan15/ADAM10 axis from confounding oncogenic mutations, we demonstrate that Tspan15 promotes cell invasion in a strictly ADAM10-dependent manner. Proteomic hiSPECS sheddome analysis identified N-cadherin as a primary substrate of the Tspan15/ADAM10 complex. Comparative immunofluorescence revealed that, among all TspanC8s, Tspan15 showed the strongest co-localization with N-cadherin. Furthermore, recombinant N-cadherin ectodomain rescued the invasion defect in Tspan15-knockout cells. Finally, this pro-invasive effect was abolished by FGFR inhibition, defining a functional Tspan15/ADAM10/N-cadherin/FGFR signaling axis. These findings provide a molecular rationale for the positional selectivity of the Tspan15/ADAM10 scissor and provide further support for the therapeutic potential of targeting this specific complex to block cancer cell invasion.
- 7 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Tspan15/ADAM10 molecular scissor promotes cell invasion through an N-cadherin/FGFR signaling axis
The ’molecular scissor’ ADAM10 is a critical regulator of cell surface signal transduction, but its therapeutic potential is constrained by the anticipated side effects of global inhibition. ADAM10 activity is governed by six regulatory tetraspanins, the TspanC8s, which dictate its substrate specificity. Among these, Tspan15 is upregulated in aggressive cancers and promotes cell invasion and cancer growth in vivo, however definitive genetic evidence for its ADAM10-dependence and its precise signaling mechanism are lacking. Utilizing HEK-293T cells to isolate the Tspan15/ADAM10 axis from confounding oncogenic mutations, we demonstrate that Tspan15 promotes cell invasion in a strictly ADAM10-dependent manner. Proteomic hiSPECS sheddome analysis identified N-cadherin as a primary substrate of the Tspan15/ADAM10 complex. Comparative immunofluorescence revealed that, among all TspanC8s, Tspan15 showed the strongest co-localization with N-cadherin. Furthermore, recombinant N-cadherin ectodomain rescued the invasion defect in Tspan15-knockout cells. Finally, this pro-invasive effect was abolished by FGFR inhibition, defining a functional Tspan15/ADAM10/N-cadherin/FGFR signaling axis. These findings provide a molecular rationale for the positional selectivity of the Tspan15/ADAM10 scissor and provide further support for the therapeutic potential of targeting this specific complex to block cancer cell invasion.
- Open Access
- 29 July 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1107
Characterising C-X-C Chemokine Receptor 4 Dynamics in the Cell Membrane Using Fluorescence Fluctuation Spectroscopy
The spatial organisation of plasma membrane proteins such as G protein-coupled receptors (GPCRs) plays a critical role in regulating cell signalling, function, and ultimately cell fate. Resolving this organisation requires techniques capable of probing dynamics at the single-molecule level with high spatial and temporal resolution. In this study, we employ the complementary fluorescence fluctuation spectroscopy approaches, Fluorescence Correlation Spectroscopy (FCS), Photon Counting Histogram Analysis (PCH), Raster Image Correlation Spectroscopy (RICS) and Number and Brightness Analysis (N&B), in conjunction with Fluorescence Recovery After Photobleaching (FRAP), to investigate the membrane organisation of the C-X-C chemokine receptor 4 (CXCR4), a GPCR known to undergo ligand-induced reorganisation. At the nanoscale, FCS highlighted opposing effects on diffusion after agonist (CXCL12) and inverse agonist (IT1t) treatment, whilst RICS also showed ligand-mediated changes in particle number. Both single-point and image-based brightness analyses (PCH and N&B) showed increased brightness after CXCL12 treatment, consistent with the pre-internalisation clustering of CXCR4. At the microscale, FRAP showed an increase in immobile CXCR4, not visible to FFS approaches, following CXCL12 stimulation. This integrated approach, performed on a single commercial confocal microscope, provides valuable insight into the reorganisation of CXCR4 in the plasma membrane over a range of temporal and spatial scales, which are not detectable using standard imaging.
- 29 July 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1107
Open AccessCharacterising C-X-C Chemokine Receptor 4 Dynamics in the Cell Membrane Using Fluorescence Fluctuation Spectroscopy
The spatial organisation of plasma membrane proteins such as G protein-coupled receptors (GPCRs) plays a critical role in regulating cell signalling, function, and ultimately cell fate. Resolving this organisation requires techniques capable of probing dynamics at the single-molecule level with high spatial and temporal resolution. In this study, we employ the complementary fluorescence fluctuation spectroscopy approaches, Fluorescence Correlation Spectroscopy (FCS), Photon Counting Histogram Analysis (PCH), Raster Image Correlation Spectroscopy (RICS) and Number and Brightness Analysis (N&B), in conjunction with Fluorescence Recovery After Photobleaching (FRAP), to investigate the membrane organisation of the C-X-C chemokine receptor 4 (CXCR4), a GPCR known to undergo ligand-induced reorganisation. At the nanoscale, FCS highlighted opposing effects on diffusion after agonist (CXCL12) and inverse agonist (IT1t) treatment, whilst RICS also showed ligand-mediated changes in particle number. Both single-point and image-based brightness analyses (PCH and N&B) showed increased brightness after CXCL12 treatment, consistent with the pre-internalisation clustering of CXCR4. At the microscale, FRAP showed an increase in immobile CXCR4, not visible to FFS approaches, following CXCL12 stimulation. This integrated approach, performed on a single commercial confocal microscope, provides valuable insight into the reorganisation of CXCR4 in the plasma membrane over a range of temporal and spatial scales, which are not detectable using standard imaging.
- Open Access
- 8 January 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (3) , 2481-2495
Two-Step Ligand-Directed Covalent Fluorescent Labeling of the Adenosine A 1 -Receptor That Maintains Its Orthosteric Binding Site’s Availability to Bind Ligands
Genetic tagging of G protein-coupled receptors (GPCRs) with bioluminescent or fluorescent proteins is a well-established method for the study of ligand-binding and protein-protein interactions using resonance energy transfer approaches. Here we present a two-step, ligand-directed covalent labeling (LDCL) method that allows attachment of different fluorescent labels to an untagged adenosine A1 receptor using click chemistry. We also describe a range of biophysical approaches to confirm that the orthosteric binding site remains available to interact with endogenous ligands, agonists and antagonists, and access to the orthosteric binding site is not sterically hindered by the transferred cargo (fluorophore or click-reactive group).
- 8 January 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (3) , 2481-2495
Open AccessTwo-Step Ligand-Directed Covalent Fluorescent Labeling of the Adenosine A 1 -Receptor That Maintains Its Orthosteric Binding Site’s Availability to Bind Ligands
Genetic tagging of G protein-coupled receptors (GPCRs) with bioluminescent or fluorescent proteins is a well-established method for the study of ligand-binding and protein-protein interactions using resonance energy transfer approaches. Here we present a two-step, ligand-directed covalent labeling (LDCL) method that allows attachment of different fluorescent labels to an untagged adenosine A1 receptor using click chemistry. We also describe a range of biophysical approaches to confirm that the orthosteric binding site remains available to interact with endogenous ligands, agonists and antagonists, and access to the orthosteric binding site is not sterically hindered by the transferred cargo (fluorophore or click-reactive group).
- Open Access
- 21 February 2025
- Published by Wiley in Journal of Microscopy
- Vol. 300 (2) , 234-249
Quantitative analysis of human umbilical vein endothelial cell morphology and tubulogenesis
Primary human umbilical vein endothelial cells can grow as both a monolayer in culture and also as a capillary‐like network making them an ideal model system in order to study vascular remodelling. Image‐based analysis can allow assessment of cell morphology and motility but is dependent on accurate cell segmentation which requires high‐contrast images not normally achievable without fluorescent markers. Here, ptychography is employed as a label‐free image‐based modality in order to extract quantitative metrics of morphology and tubulogenesis from cultured HUVECs over time in an automated multiwell assay. Phase‐specific parameters of dry mass, optical thickness and sphericity were extracted and assessed alongside other metrics of cell number and shape. Tubulogenesis could be captured dynamically without any imaging artefacts from use of a basement membrane matrix and metrics of tube number, growth and branching exported alongside morphology metrics at early time‐points. Utilising ptychography‐based image analysis, all VEGF165a isoforms studied, elicited a concentration‐dependent effect on cell elongation and survival within a HUVEC monolayer. Pharmacologically relevant parameters of potency (EC50) and efficacy were derived, exemplifying this label‐free approach for the multiparameter and multiwell quantitative study of vascular remodelling in physiologically relevant cells at 37°C.
- 21 February 2025
- Published by Wiley in Journal of Microscopy
- Vol. 300 (2) , 234-249
Open AccessQuantitative analysis of human umbilical vein endothelial cell morphology and tubulogenesis
Primary human umbilical vein endothelial cells can grow as both a monolayer in culture and also as a capillary‐like network making them an ideal model system in order to study vascular remodelling. Image‐based analysis can allow assessment of cell morphology and motility but is dependent on accurate cell segmentation which requires high‐contrast images not normally achievable without fluorescent markers. Here, ptychography is employed as a label‐free image‐based modality in order to extract quantitative metrics of morphology and tubulogenesis from cultured HUVECs over time in an automated multiwell assay. Phase‐specific parameters of dry mass, optical thickness and sphericity were extracted and assessed alongside other metrics of cell number and shape. Tubulogenesis could be captured dynamically without any imaging artefacts from use of a basement membrane matrix and metrics of tube number, growth and branching exported alongside morphology metrics at early time‐points. Utilising ptychography‐based image analysis, all VEGF165a isoforms studied, elicited a concentration‐dependent effect on cell elongation and survival within a HUVEC monolayer. Pharmacologically relevant parameters of potency (EC50) and efficacy were derived, exemplifying this label‐free approach for the multiparameter and multiwell quantitative study of vascular remodelling in physiologically relevant cells at 37°C.
- Open Access
- 12 July 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (14) , 12099-12117
Ligand-Directed Labeling of the Adenosine A1 Receptor in Living Cells
The study of protein function and dynamics in their native cellular environment is essential for progressing fundamental science. To overcome the requirement of genetic modification of the protein or the limitations of dissociable fluorescent ligands, ligand-directed (LD) chemistry has most recently emerged as a complementary, bioorthogonal approach for labeling native proteins. Here, we describe the rational design, development, and application of the first ligand-directed chemistry approach for labeling the A1AR in living cells. We pharmacologically demonstrate covalent labeling of A1AR expressed in living cells while the orthosteric binding site remains available. The probes were imaged using confocal microscopy and fluorescence correlation spectroscopy to study A1AR localization and dynamics in living cells. Additionally, the probes allowed visualization of the specific localization of A1ARs endogenously expressed in dorsal root ganglion (DRG) neurons. LD probes developed here hold promise for illuminating ligand-binding, receptor signaling, and trafficking of the A1AR in more physiologically relevant environments.
- 12 July 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (14) , 12099-12117
Open AccessLigand-Directed Labeling of the Adenosine A1 Receptor in Living Cells
The study of protein function and dynamics in their native cellular environment is essential for progressing fundamental science. To overcome the requirement of genetic modification of the protein or the limitations of dissociable fluorescent ligands, ligand-directed (LD) chemistry has most recently emerged as a complementary, bioorthogonal approach for labeling native proteins. Here, we describe the rational design, development, and application of the first ligand-directed chemistry approach for labeling the A1AR in living cells. We pharmacologically demonstrate covalent labeling of A1AR expressed in living cells while the orthosteric binding site remains available. The probes were imaged using confocal microscopy and fluorescence correlation spectroscopy to study A1AR localization and dynamics in living cells. Additionally, the probes allowed visualization of the specific localization of A1ARs endogenously expressed in dorsal root ganglion (DRG) neurons. LD probes developed here hold promise for illuminating ligand-binding, receptor signaling, and trafficking of the A1AR in more physiologically relevant environments.
- Open Access
- 21 June 2024
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 12 (4) , e1223
A novel and selective fluorescent ligand for the study of adenosine A2B receptors
Fluorescent ligands have proved to be powerful tools in the study of G protein‐coupled receptors in living cells. Here we have characterized a new fluorescent ligand PSB603‐BY630 that has high selectivity for the human adenosine A2B receptor (A2BR). The A2BR appears to play an important role in regulating immune responses in the tumor microenvironment. Here we have used PSB603‐BY630 to monitor specific binding to A2BRs in M1‐ and M2‐like macrophages derived from CD14+ human monocytes. PSB603‐BY630 bound with high affinity (18.3 nM) to nanoluciferase‐tagged A2BRs stably expressed in HEK293G cells. The ligand exhibited very high selectivity for the A2BR with negligible specific‐binding detected at NLuc‐A2AR, NLuc‐A1R, or NLuc‐A3R receptors at concentrations up to 500 nM. Competition binding studies showed the expected pharmacology at A2BR with the A2BR‐selective ligands PSB603 and MRS‐1706 demonstrating potent inhibition of the specific binding of 50 nM PSB603‐BY630 to A2BR. Functional studies in HEK293G cells using Glosensor to monitor Gs‐coupled cyclic AMP responses indicated that PSB603‐BY630 acted as a negative allosteric regular of the agonist responses to BAY 60–6583. Furthermore, flow cytometry analysis confirmed that PSB603‐BY630 could be used to selectively label endogenous A2BRs expressed on human macrophages. This ligand should be an important addition to the library of fluorescent ligands which are selective for the different adenosine receptor subtypes, and will enable study of the role of A2BRs on immune cells in the tumor microenvironment.
- 21 June 2024
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 12 (4) , e1223
Open AccessA novel and selective fluorescent ligand for the study of adenosine A2B receptors
Fluorescent ligands have proved to be powerful tools in the study of G protein‐coupled receptors in living cells. Here we have characterized a new fluorescent ligand PSB603‐BY630 that has high selectivity for the human adenosine A2B receptor (A2BR). The A2BR appears to play an important role in regulating immune responses in the tumor microenvironment. Here we have used PSB603‐BY630 to monitor specific binding to A2BRs in M1‐ and M2‐like macrophages derived from CD14+ human monocytes. PSB603‐BY630 bound with high affinity (18.3 nM) to nanoluciferase‐tagged A2BRs stably expressed in HEK293G cells. The ligand exhibited very high selectivity for the A2BR with negligible specific‐binding detected at NLuc‐A2AR, NLuc‐A1R, or NLuc‐A3R receptors at concentrations up to 500 nM. Competition binding studies showed the expected pharmacology at A2BR with the A2BR‐selective ligands PSB603 and MRS‐1706 demonstrating potent inhibition of the specific binding of 50 nM PSB603‐BY630 to A2BR. Functional studies in HEK293G cells using Glosensor to monitor Gs‐coupled cyclic AMP responses indicated that PSB603‐BY630 acted as a negative allosteric regular of the agonist responses to BAY 60–6583. Furthermore, flow cytometry analysis confirmed that PSB603‐BY630 could be used to selectively label endogenous A2BRs expressed on human macrophages. This ligand should be an important addition to the library of fluorescent ligands which are selective for the different adenosine receptor subtypes, and will enable study of the role of A2BRs on immune cells in the tumor microenvironment.
- Open Access
- 21 March 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (7) , 5208-5222
Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
- 21 March 2023
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 66 (7) , 5208-5222
Open AccessSmall-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
- Open Access
- 1 January 2022
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (1) , 19-29.e6
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET
- 1 January 2022
- Published by Elsevier in Cell Chemical Biology
- Vol. 29 (1) , 19-29.e6
Open AccessProbing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET
- Open Access
- 18 May 2021
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 9 (3) , e00779
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
Fluorescent ligand technologies have proved to be powerful tools to improve our understanding of ligand‐receptor interactions. Here we have characterized a small focused library of nine fluorescent ligands based on the highly selective β2‐adrenoceptor (β2AR) antagonist ICI 118,551. The majority of fluorescent ICI 118,551 analogs had good affinity for the β2AR (pKD >7.0) with good selectivity over the β1AR (pKD 8c (ICI 118,551‐Gly‐Ala‐BODIPY‐FL‐X; β2AR pKD 7.48), 9c (ICI 118,551‐βAla‐βAla‐BODIPY‐FL‐X; β2AR pKD 7.48), 12a (ICI 118,551‐PEG‐BODIPY‐X‐630/650; β2AR pKD 7.56), and 12b (ICI 118,551‐PEG‐BODIPY‐FL; β2AR pKD 7.42). 9a (ICI 118,551‐βAla‐βAla‐BODIPY‐X‐630/650) had the highest affinity at recombinant β2ARs (pKD 7.57), but also exhibited significant binding affinity to the β1AR (pKD 6.69). Nevertheless, among the red fluorescent ligands, 9a had the best imaging characteristics in recombinant HEK293 T cells and labeling was mostly confined to the cell surface. In contrast, 12a showed the highest propensity to label intracellular β2ARs in HEK293 T cell expressing exogenous β2ARs. This suggests that a combination of the polyethylene glycol (PEG) linker and the BODIPY‐X‐630/650 makes this ICI 118,551 derivative particularly susceptible to crossing the cell membrane to access the intracellular β2ARs. We have also used these ligands in combination with CRISPR/Cas9 genome‐edited HEK293 T cells to undertake for the first time real‐time ligand binding to native HEK293 T β2ARs at low native receptor expression levels. These studies provided quantitative data on ligand‐binding characteristics but also allowed real‐time visualization of the ligand‐binding interactions in genome‐edited cells using NanoBRET luminescence imaging.
- 18 May 2021
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 9 (3) , e00779
Open AccessSubtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
Fluorescent ligand technologies have proved to be powerful tools to improve our understanding of ligand‐receptor interactions. Here we have characterized a small focused library of nine fluorescent ligands based on the highly selective β2‐adrenoceptor (β2AR) antagonist ICI 118,551. The majority of fluorescent ICI 118,551 analogs had good affinity for the β2AR (pKD >7.0) with good selectivity over the β1AR (pKD 8c (ICI 118,551‐Gly‐Ala‐BODIPY‐FL‐X; β2AR pKD 7.48), 9c (ICI 118,551‐βAla‐βAla‐BODIPY‐FL‐X; β2AR pKD 7.48), 12a (ICI 118,551‐PEG‐BODIPY‐X‐630/650; β2AR pKD 7.56), and 12b (ICI 118,551‐PEG‐BODIPY‐FL; β2AR pKD 7.42). 9a (ICI 118,551‐βAla‐βAla‐BODIPY‐X‐630/650) had the highest affinity at recombinant β2ARs (pKD 7.57), but also exhibited significant binding affinity to the β1AR (pKD 6.69). Nevertheless, among the red fluorescent ligands, 9a had the best imaging characteristics in recombinant HEK293 T cells and labeling was mostly confined to the cell surface. In contrast, 12a showed the highest propensity to label intracellular β2ARs in HEK293 T cell expressing exogenous β2ARs. This suggests that a combination of the polyethylene glycol (PEG) linker and the BODIPY‐X‐630/650 makes this ICI 118,551 derivative particularly susceptible to crossing the cell membrane to access the intracellular β2ARs. We have also used these ligands in combination with CRISPR/Cas9 genome‐edited HEK293 T cells to undertake for the first time real‐time ligand binding to native HEK293 T β2ARs at low native receptor expression levels. These studies provided quantitative data on ligand‐binding characteristics but also allowed real‐time visualization of the ligand‐binding interactions in genome‐edited cells using NanoBRET luminescence imaging.
- Open Access
- 12 March 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (4) , e21398
The use of fluorescence correlation spectroscopy to monitor cell surface β2‐adrenoceptors at low expression levels in human embryonic stem cell‐derived cardiomyocytes and fibroblasts
The importance of cell phenotype in determining the molecular mechanisms underlying β 2 ‐adrenoceptor (β2AR) function has been noted previously when comparing responses in primary cells and recombinant model cell lines. Here, we have generated haplotype‐specific SNAP‐tagged β2AR human embryonic stem (ES) cell lines and applied fluorescence correlation spectroscopy (FCS) to study cell surface receptors in progenitor cells and in differentiated fibroblasts and cardiomyocytes. FCS was able to quantify SNAP‐tagged β2AR number and diffusion in both ES‐derived cardiomyocytes and CRISPR/Cas9 genome‐edited HEK293T cells, where the expression level was too low to detect using standard confocal microscopy. These studies demonstrate the power of FCS in investigating cell surface β2ARs at the very low expression levels often seen in endogenously expressing cells. Furthermore, the use of ES cell technology in combination with FCS allowed us to demonstrate that cell surface β2ARs internalize in response to formoterol‐stimulation in ES progenitor cells but not following their differentiation into ES‐derived fibroblasts. This indicates that the process of agonist‐induced receptor internalization is strongly influenced by cell phenotype and this may have important implications for drug treatment with long‐acting β2AR agonists.
- 12 March 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (4) , e21398
Open AccessThe use of fluorescence correlation spectroscopy to monitor cell surface β2‐adrenoceptors at low expression levels in human embryonic stem cell‐derived cardiomyocytes and fibroblasts
The importance of cell phenotype in determining the molecular mechanisms underlying β 2 ‐adrenoceptor (β2AR) function has been noted previously when comparing responses in primary cells and recombinant model cell lines. Here, we have generated haplotype‐specific SNAP‐tagged β2AR human embryonic stem (ES) cell lines and applied fluorescence correlation spectroscopy (FCS) to study cell surface receptors in progenitor cells and in differentiated fibroblasts and cardiomyocytes. FCS was able to quantify SNAP‐tagged β2AR number and diffusion in both ES‐derived cardiomyocytes and CRISPR/Cas9 genome‐edited HEK293T cells, where the expression level was too low to detect using standard confocal microscopy. These studies demonstrate the power of FCS in investigating cell surface β2ARs at the very low expression levels often seen in endogenously expressing cells. Furthermore, the use of ES cell technology in combination with FCS allowed us to demonstrate that cell surface β2ARs internalize in response to formoterol‐stimulation in ES progenitor cells but not following their differentiation into ES‐derived fibroblasts. This indicates that the process of agonist‐induced receptor internalization is strongly influenced by cell phenotype and this may have important implications for drug treatment with long‐acting β2AR agonists.